Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment
Identifieur interne : 000B53 ( Istex/Checkpoint ); précédent : 000B52; suivant : 000B54Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment
Auteurs : Pauline Belujon [États-Unis] ; Daniel J. Lodge [États-Unis] ; Anthony A. Grace [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010-08-15.
English descriptors
Abstract
Chronic levodopa treatment for Parkinson's disease often results in the development of abnormal involuntary movement, known as L‐dopa‐induced dyskinesia (LIDs). Studies suggest that LIDs may be associated with aberrant corticostriatal plasticity. Using in vivo extracellular recordings from identified Type I and Type II medium spiny striatal neurons, chronic L‐dopa treatment was found to produce abnormal corticostriatal information processing. Specifically, after chronic L‐dopa treatment in dopamine‐depleted rats, there was a transition from a cortically evoked long‐term depression (LTD) to a complementary but opposing form of plasticity, long‐term potentiation, in Type II “indirect” pathway neurons. In contrast, LTD could still be induced in Type I neurons. Interestingly, the one parameter that correlated best with dyskinesias was the inability to de‐depress established LTD in Type I medium spiny striatal neurons. Taken as a whole, we propose that the induction of LIDs is due, at least in part, to an aberrant induction of plasticity within the Type II indirect pathway neurons combined with an inability to de‐depress established plastic responses in Type I neurons. Such information is critical for understanding the cellular mechanisms underlying one of the major caveats to L‐dopa therapy. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.23245
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:DB8EDA6676CB1F8C57A2E09D1FD030B4322EF91DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment</title><author><name sortKey="Belujon, Pauline" sort="Belujon, Pauline" uniqKey="Belujon P" first="Pauline" last="Belujon">Pauline Belujon</name></author><author><name sortKey="Lodge, Daniel J" sort="Lodge, Daniel J" uniqKey="Lodge D" first="Daniel J." last="Lodge">Daniel J. Lodge</name></author><author><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DB8EDA6676CB1F8C57A2E09D1FD030B4322EF91D</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.23245</idno><idno type="url">https://api.istex.fr/document/DB8EDA6676CB1F8C57A2E09D1FD030B4322EF91D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000A84</idno><idno type="wicri:Area/Istex/Curation">000A84</idno><idno type="wicri:Area/Istex/Checkpoint">000B53</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment</title><author><name sortKey="Belujon, Pauline" sort="Belujon, Pauline" uniqKey="Belujon P" first="Pauline" last="Belujon">Pauline Belujon</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">Pittsburgh</settlement></placeName><orgName type="university">Université de Pittsburgh</orgName></affiliation></author><author><name sortKey="Lodge, Daniel J" sort="Lodge, Daniel J" uniqKey="Lodge D" first="Daniel J." last="Lodge">Daniel J. Lodge</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">Pittsburgh</settlement></placeName><orgName type="university">Université de Pittsburgh</orgName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Current Address: Department of Pharmacology, UTHSCSA, San Antonio, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neuroscience, Psychiatry, and Psychology, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">Pittsburgh</settlement></placeName><orgName type="university">Université de Pittsburgh</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-08-15">2010-08-15</date><biblScope unit="vol">25</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1568">1568</biblScope><biblScope unit="page" to="1576">1576</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">DB8EDA6676CB1F8C57A2E09D1FD030B4322EF91D</idno><idno type="DOI">10.1002/mds.23245</idno><idno type="ArticleID">MDS23245</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>basal ganglia</term><term>dopamine</term><term>motor cortex</term><term>synaptic plasticity</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Chronic levodopa treatment for Parkinson's disease often results in the development of abnormal involuntary movement, known as L‐dopa‐induced dyskinesia (LIDs). Studies suggest that LIDs may be associated with aberrant corticostriatal plasticity. Using in vivo extracellular recordings from identified Type I and Type II medium spiny striatal neurons, chronic L‐dopa treatment was found to produce abnormal corticostriatal information processing. Specifically, after chronic L‐dopa treatment in dopamine‐depleted rats, there was a transition from a cortically evoked long‐term depression (LTD) to a complementary but opposing form of plasticity, long‐term potentiation, in Type II “indirect” pathway neurons. In contrast, LTD could still be induced in Type I neurons. Interestingly, the one parameter that correlated best with dyskinesias was the inability to de‐depress established LTD in Type I medium spiny striatal neurons. Taken as a whole, we propose that the induction of LIDs is due, at least in part, to an aberrant induction of plasticity within the Type II indirect pathway neurons combined with an inability to de‐depress established plastic responses in Type I neurons. Such information is critical for understanding the cellular mechanisms underlying one of the major caveats to L‐dopa therapy. © 2010 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li><li>Texas</li></region><settlement><li>Pittsburgh</li></settlement><orgName><li>Université de Pittsburgh</li></orgName></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Belujon, Pauline" sort="Belujon, Pauline" uniqKey="Belujon P" first="Pauline" last="Belujon">Pauline Belujon</name></region><name sortKey="Grace, Anthony A" sort="Grace, Anthony A" uniqKey="Grace A" first="Anthony A." last="Grace">Anthony A. Grace</name><name sortKey="Lodge, Daniel J" sort="Lodge, Daniel J" uniqKey="Lodge D" first="Daniel J." last="Lodge">Daniel J. Lodge</name><name sortKey="Lodge, Daniel J" sort="Lodge, Daniel J" uniqKey="Lodge D" first="Daniel J." last="Lodge">Daniel J. Lodge</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000B53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:DB8EDA6676CB1F8C57A2E09D1FD030B4322EF91D
|texte= Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment
}}
| This area was generated with Dilib version V0.6.23. |  |